{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T12:07:49Z","timestamp":1759838869782},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T00:00:00Z","timestamp":1350432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s11033-012-2079-9","type":"journal-article","created":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T18:40:46Z","timestamp":1350499246000},"page":"449-455","source":"Crossref","is-referenced-by-count":11,"title":["Interleukin-6 gene \u2212174G>C and \u2212636G>C promoter polymorphisms and prostate cancer risk"],"prefix":"10.1007","volume":"40","author":[{"given":"J. F.","family":"Magalh\u00e3es","sequence":"first","affiliation":[]},{"given":"A. J.","family":"Cortinhas","sequence":"additional","affiliation":[]},{"given":"C. M.","family":"Albuquerque","sequence":"additional","affiliation":[]},{"given":"C. S.","family":"Baptista","sequence":"additional","affiliation":[]},{"given":"R.","family":"Ribeiro","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Viegas","sequence":"additional","affiliation":[]},{"given":"Augusto","family":"Matos","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Machado","sequence":"additional","affiliation":[]},{"given":"Maria A.","family":"Pires","sequence":"additional","affiliation":[]},{"given":"Henrique","family":"Guedes-Pinto","sequence":"additional","affiliation":[]},{"given":"A.","family":"Martins-Bessa","sequence":"additional","affiliation":[]},{"given":"J. C.","family":"Leit\u00e3o","sequence":"additional","affiliation":[]},{"given":"E.","family":"Bastos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,10,17]]},"reference":[{"issue":"2","key":"2079_CR1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/mnfr.200700511","volume":"53","author":"PD Baade","year":"2009","unstructured":"Baade PD, Youlden DR, Kmjacki LJ (2009) International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res 53(2):171\u2013184","journal-title":"Mol Nutr Food Res"},{"issue":"8","key":"2079_CR2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/molehr\/gag064","volume":"9","author":"WA Schulz","year":"2003","unstructured":"Schulz WA, Burchardt M, Cronauer MV (2003) Molecular biology of prostate cancer. Mol Hum Reprod 9(8):437\u2013448. doi: 10.1093\/molehr\/gag064","journal-title":"Mol Hum Reprod"},{"issue":"7","key":"2079_CR3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/jcp.2002.003954","volume":"58","author":"C Hughes","year":"2005","unstructured":"Hughes C, Murphy A, Martin C, Sheils O, O\u2032Leary J (2005) Molecular pathology of prostate cancer. J Clin Pathol 58(7):673\u2013684. doi: 10.1136\/jcp.2002.003954","journal-title":"J Clin Pathol"},{"issue":"18","key":"2079_CR4","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1101\/gad.1965810","volume":"24","author":"MM Shen","year":"2010","unstructured":"Shen MM, Abate-Shen C (2010) Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev 24(18):1967\u20132000. doi: 10.1101\/gad.1965810","journal-title":"Genes Dev"},{"issue":"2","key":"2079_CR5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/01.ju.0000168723.42824.40","volume":"174","author":"D Tan","year":"2005","unstructured":"Tan D, Wu X, Hou M, Lee SO, Lou W, Wang J, Janarthan B, Nallapareddy S, Trump DL, Gao AC (2005) Interleukin-6 polymorphism is associated with more aggressive prostate cancer. J Urol 174(2):753\u2013756. doi: 10.1097\/01.ju.0000168723.42824.40","journal-title":"J Urol"},{"key":"2079_CR6","doi-asserted-by":"crossref","unstructured":"Culig Z, Puhr M (2011) Interleukin-6: a multifunctional targetable cytokine in human prostate cancer. Mol Cell Endocrinol. doi: 10.1016\/j.mce.2011.05.033","DOI":"10.1016\/j.mce.2011.05.033"},{"issue":"4","key":"2079_CR7","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1007\/s11033-010-0399-1","volume":"38","author":"B Xu","year":"2011","unstructured":"Xu B, Niu XB, Wang ZD, Cheng W, Tong N, Mi YY, Min ZC, Tao J, Li PC, Zhang W, Wu HF, Zhang ZD, Wang ZJ, Hua LX, Feng NH, Wang XR (2011) IL-6 \u2212174G>C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controls. Mol Biol Rep 38(4):2589\u20132596. doi: 10.1007\/s11033-010-0399-1","journal-title":"Mol Biol Rep"},{"issue":"7","key":"2079_CR8","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s10552-009-9320-4","volume":"20","author":"BL Pierce","year":"2009","unstructured":"Pierce BL, Biggs ML, DeCambre M, Reiner AP, Li C, Fitzpatrick A, Carlson CS, Stanford JL, Austin MA (2009) C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65\u00a0years and older. Cancer Causes Control 20(7):1193\u20131203. doi: 10.1007\/s10552-009-9320-4","journal-title":"Cancer Causes Control"},{"issue":"8","key":"2079_CR9","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1136\/jnnp.2005.081976","volume":"77","author":"L Morgan","year":"2006","unstructured":"Morgan L, Cooper J, Montgomery H, Kitchen N, Humphries SE (2006) The interleukin-6 gene \u2212174G>C and \u2212572G>C promoter polymorphisms are related to cerebral aneurysms. J Neurol Neurosurg Psychiatry 77(8):915\u2013917. doi: 10.1136\/jnnp.2005.081976","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"2079_CR10","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1158\/1055-9965.1677.13.10","volume":"13","author":"J Sun","year":"2004","unstructured":"Sun J, Hedelin M, Zheng SL, Adami HO, Bensen J, Augustsson-Balter K, Chang B, Adolfsson J, Adams T, Turner A, Meyers DA, Isaacs WB, Xu J, Gronberg H (2004) Interleukin-6 sequence variants are not associated with prostate cancer risk. Cancer Epidemiol Biomark Prev 13(10):1677\u20131679","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"8","key":"2079_CR11","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1158\/0008-5472.CAN-05-3987","volume":"66","author":"DS Michaud","year":"2006","unstructured":"Michaud DS, Daugherty SE, Berndt SI, Platz EA, Yeager M, Crawford ED, Hsing A, Huang WY, Hayes RB (2006) Genetic polymorphisms of Interleukin-1B(IL-1B), IL-6, IL-8 and IL-10 and risk of prostate cancer. Cancer Res 66(8):4525\u20134530. doi: 1158\/0008-5472.CAN-05-3987","journal-title":"Cancer Res"},{"issue":"6","key":"2079_CR12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s11596-008-0618-3","volume":"28","author":"S Bao","year":"2008","unstructured":"Bao S, Yang W, Zhou S, Ye Z (2008) Relationship between single nucleotide polymorphisms in \u2212174G\/C and \u2212634C\/G promoter region of interleukin-6 and prostate cancer. J Huazhong Univ Sci Technol 28(6):693\u2013696. doi: 10.1007\/s11596-008-0618-3","journal-title":"J Huazhong Univ Sci Technol"},{"issue":"9","key":"2079_CR13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/dna.2008.0742","volume":"27","author":"P Kesarwani","year":"2008","unstructured":"Kesarwani P, Ahirwar DK, Mandhani A, Mittal RD (2008) Association between \u2212174 G\/C promoter polymorphism of the Interleukin-6 gene and progression of prostate cancer in North Indian population. DNA Cell Biol 27(9):505\u2013509. doi: 10.1089\/dna.2008.0742","journal-title":"DNA Cell Biol"},{"issue":"4","key":"2079_CR14","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ijc.24043","volume":"124","author":"SC Moore","year":"2009","unstructured":"Moore SC, Leitzmann MF, Albanes D, Weinstein SJ, Snyder K, Virtamo J, Ahn J, Mayne ST, Yu H, Peters U, Gunter MJ (2009) Adipokine genes and prostate cancer risk. Int J Cancer 124(4):869\u2013876. doi: 10.1002\/ijc.24043","journal-title":"Int J Cancer"},{"issue":"8","key":"2079_CR15","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/pros.20933","volume":"69","author":"M Wang","year":"2009","unstructured":"Wang M, Helzlsouer KJ, Smith MW, Hoffman-Bolton JA, Clipp SL, Grinberg V, Marzo AM, Isaacs WB, Drake CG, Shugart YY, Platz EA (2009) Association of IL-10 and other immune response\u2013and obesity-related genes with prostate cancer in CLUE II. Prostate 69(8):874\u2013885. doi: 10.1002\/pros.20933","journal-title":"Prostate"},{"issue":"8","key":"2079_CR16","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/carcin\/bgp124","volume":"30","author":"J Zabaleta","year":"2009","unstructured":"Zabaleta J, Su LJ, Lin HY, Sierra RA, Hall MC, Sartor AO, Clark PE, Hu JJ, Ochoa AC (2009) Cytokine genetic polymorphisms and prostate cancer aggressiveness. Carcinogenesis 30(8):1358\u20131362. doi: 10.1093\/carcin\/bgp124","journal-title":"Carcinogenesis"},{"issue":"3","key":"2079_CR17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/carcin\/bgp307","volume":"31","author":"L Dossus","year":"2010","unstructured":"Dossus L, Kaaks R, Canzian F, Albanes D, Berndt SI, Boeing H, Buring J, Chanock SJ, Clavel-Chapelon F, Feigelson HS, Gaziano JM, Giovannuci E, Gonzalez C, Haiman CA, Hallmans G, Hankinson SE, Hayes RB, Henderson BE, Hoover RN, Hunter DJ, Khaw KT, Kolonel LN, Kraft P, Ma J, Marchand LL, Lund E, Peeters PHM, Stampfer M, Stram DO, Thomas G, Thun MJ, Tjonneland A, Trichopoulos D, Tumino R, Riboli E, Virtamo J, Weinstein SJ, Yeager M, Ziegler G, Cox DG (2010) PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium. Carcinogenesis 31(3):455\u2013461. doi: 10.1093\/carcin\/bgp307","journal-title":"Carcinogenesis"},{"key":"2079_CR18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/jn\/137.1.194S","volume":"137","author":"WM Howell","year":"2007","unstructured":"Howell WM, Rose-Zerilli MJ (2007) Cytokine gene polymorphisms, cancer susceptibility and prognosis. J Nutr 137:194\u2013199","journal-title":"J Nutr"},{"issue":"6","key":"2079_CR19","first-page":"321","volume":"41","author":"HM Ahn","year":"2011","unstructured":"Ahn HM, Park IS, Hong SJ, Hong YM (2011) Interleukin-6 (\u2212636C\/G) gene polymorphism in Korean children with Kawasaki Disease. Korean Soc Cardiol 41(6):321\u2013325. doi: 104070\/kcj.2011.41.6.321","journal-title":"Korean Soc Cardiol"},{"issue":"7","key":"2079_CR20","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","volume":"102","author":"D Fishman","year":"1998","unstructured":"Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102(7):1369\u20131376. doi: 10.1172\/JCI2629","journal-title":"J Clin Invest"},{"key":"2079_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.immunol.23.021704.115806","volume":"23","author":"T Kishimoto","year":"2005","unstructured":"Kishimoto T (2005) Interleukin-6: from basic science to medicine. Annu Rev Immunol 23:1\u201321. doi: 10.1146\/annurev.immunol.23.021704.115806","journal-title":"Annu Rev Immunol"},{"key":"2079_CR22","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/sj.bjc.6605358","volume":"101","author":"T Terakawa","year":"2009","unstructured":"Terakawa T, Miyake H, Furukawa J, Ettinger SL, Gleave ME, Fujisawa M (2009) Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells. Br J Cancer 101:1731\u20131739. doi: 10.1038\/sj.bjc.6605358","journal-title":"Br J Cancer"},{"issue":"14","key":"2079_CR23","first-page":"1","volume":"5","author":"GH Lyman","year":"2005","unstructured":"Lyman GH, Kuderer NM (2005) The strengths and limitations of meta-analyses based on aggregate data. BMC Med Res Methodol 5(14):1\u201317. doi: 10.1186\/1471-2288-5-14","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"2079_CR24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3949\/ccjm.75.6.431","volume":"75","author":"E Walker","year":"2008","unstructured":"Walker E, Hernandez AV, Kattan MW (2008) Meta-analysis: its strengths and limitations. Cleve Clin J Med 75(6):431\u2013439. doi: 10.3949\/ccjm.75.6.431","journal-title":"Cleve Clin J Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-012-2079-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-012-2079-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-012-2079-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T07:43:58Z","timestamp":1687765438000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-012-2079-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,17]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["2079"],"URL":"https:\/\/doi.org\/10.1007\/s11033-012-2079-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,17]]}}}